IBDoc in Press

Introducing Patient Home Tests for Calprotectin in a Routine District General Hospital

Read a recent interview with Lead Inflammatory Bowel Disease Nurse, Pearl Avery, conducted by BÜHLMANN’s UK distributor Alpha Laboratories Highlight the Article: “In the six months that we have been working with the IBDoc®, one patient was saved from hospital admission. It looked like they were having an IBD flare but the symptoms were actually […]

Introducing Patient Home Tests for Calprotectin in a Routine District General Hospital Read More »

IBDoc – SwissMedtech Award Nominee

At this year’s SwissMedtech Day, BÜHLMANN was nominated to receive the Swiss Medtech Award. Switzerland is listed by key rankings as the “globally most innovative country”. Medtech one of the industries heavily contributing to this ranking. Out of 25 applications BÜHLMANN Laboratories AG was chosen to present IBDoc® to a Jury of medtech and academic

IBDoc – SwissMedtech Award Nominee Read More »

IBDoc is now part of the TactioRPM

Tactio Health Group and Telia Company team up to accelerate the development of patient-centred digital health programs in Sweden and other Nordic and Baltic countries. The Swedish telecommunication company Telia, together with AbbVie Sweden, developed the IBD Home platform using the  TactioRPM platform. IBD Home is a complete IBD remote monitoring ecosystem. The IBD Home app

IBDoc is now part of the TactioRPM Read More »


Read a recent post from Amanda Appleton, the Product Manager for Calprotectin at our UK distributor Alpha Laboratories. She ends the article with following sentence: “App technology has the ability not only to improve the health of patients but to save money through rapid optimisation of treatment, enable early interventions through monitoring before conditions get


Health Care Business Award for IBDoc

For the second year, Boussias Communications and Health Daily organized the Healthcare Business Awards 2017 in Greece. The award is meant to showcase and reward innovative healthcare actions. This year the AbbVie Greece received the Gold Award in the Health Innovation category. Together with BÜHLMANN Laboratories AG and the home care provider PCC Hellas AbbVie implemented IBDoc® into their Care Programm for patients suffering

Health Care Business Award for IBDoc Read More »

UEGW 2015 News

  This year the United European Gastroenterology Week took place from October 24th to 28th in Barcelona. Over 13 000 participants from 114 countries were present. The BÜHLMANN team was among the 2325 exhibitors. This year’s UEGW marked an important event for us with the publication of the first clinical usability evaluation  of IBDoc®. The data

UEGW 2015 News Read More »